Physician profile
Maneesh Gupta
NPI 1417271420
$4,710.18
in general payments reported to CMS, 2019-2025
33 companies · $766 in 2025
The $766 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $348 · 2021: $494 · 2022: $435 · 2023: $1,217 · 2024: $1,267 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,495 · Travel and Lodging: $741 · Education: $13.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,494.87 |
| Travel and Lodging | $741.17 |
| Education | $13.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,255.41 | 2019-2025 | |
| Medtronic, INC. | $1,175.44 | 2021-2025 | Interstim, Pillcam |
| Takeda Pharmaceuticals U.S.A., INC. | $365.40 | 2019-2025 | Entyvio, Gattex |
| Genzyme Corporation | $242.31 | 2023-2025 | |
| Janssen Biotech, INC. | $231.24 | 2020-2025 | Stelara, Tremfya, Simponi Aria |
| Gilead Sciences, INC. | $170.27 | 2021-2025 | |
| Pfizer INC. | $159.27 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.49 | 2020-2025 | Xifaxan, Relistor |
| Phathom Pharmaceuticals, INC. | $118.34 | 2024-2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $115.70 | 2023 | Zeposia |
| Celgene Corporation | $108.59 | 2023-2024 | Zeposia |
| Intuitive Surgical, INC. | $91.20 | 2019 | |
| Celltrion USA INC. | $72.76 | 2024-2025 | Vegzelma, Zymfentra |
| Ardelyx, INC. | $66.95 | 2023-2025 | Ibsrela |
| Qol Medical, LLC | $64.59 | 2019-2025 | Sucraid, Sucraid |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $64.25 | 2020-2023 | Linzess |
| Daiichi Sankyo INC. | $35.47 | 2021-2023 | Injectafer |
| Shield Therapeutics INC | $20.20 | 2023 | Accrufer |
| Ipsen Biopharmaceuticals, INC | $18.19 | 2025 | Iqirvo |
| Novo Nordisk INC | $17.83 | 2025 | Wegovy |
| Nestle Healthcare Nutrition INC. | $17.21 | 2021 | |
| Evoke Pharma, INC. | $17.18 | 2024 | |
| Lilly USA, LLC | $16.73 | 2025 | Omvoh |
| Amgen INC. | $15.46 | 2023 | Avsola, Amjevita |
| Concordia Pharmaceuticals INC. | $14.92 | 2019 | |
| Alnylam Pharmaceuticals INC. | $14.88 | 2025 | Givlaari |
| Braintree Laboratories, INC. | $14.56 | 2025 | Suflave, Sutab |
| Mallinckrodt Hospital Products INC. | $14.42 | 2023 | Terlivaz |
| Madrigal Pharmaceuticals | $13.84 | 2025 | Rezdiffra |
| Romark Laboratories, Lc | $13.75 | 2020 | |
| Merck Sharp & Dohme LLC | $13.70 | 2019 | |
| Valinor Pharma, LLC | $13.09 | 2023 | Movantik |
| Intercept Pharmaceuticals, INC. | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maneesh Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.